Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease.

PubWeight™: 1.66‹?› | Rank: Top 3%

🔗 View Article (PMC 1020907)

Published in Thorax on January 01, 1991

Authors

L B Palmer1, H E Greenberg, M J Schiff

Author Affiliations

1: Department of Medicine, North Shore University Hospital, Cornell University Medical Center, Manhasset, New York 11030.

Articles citing this

Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev (1999) 12.90

Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care (2006) 1.76

Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun (1997) 1.61

Human dendritic cells following Aspergillus fumigatus infection express the CCR7 receptor and a differential pattern of interleukin-12 (IL-12), IL-23, and IL-27 cytokines, which lead to a Th1 response. Infect Immun (2006) 1.02

Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series. BMC Gastroenterol (2007) 0.93

Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis. J Cyst Fibros (2009) 0.92

Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients. Antimicrob Agents Chemother (1994) 0.90

A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host. Thorax (2000) 0.89

Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection. J Clin Microbiol (1996) 0.83

What are fungal infections? Mediterr J Hematol Infect Dis (2011) 0.78

Challenges in prevention, diagnosis and therapy of emerging fungal diseases. Aspergillosis: A case study. Indian J Clin Biochem (2000) 0.78

Roles of Autophagy and Autophagy-Related Proteins in Antifungal Immunity. Front Immunol (2016) 0.77

The Role of Open Lung Biopsy in Critically Ill Patients with Hypoxic Respiratory Failure: A Retrospective Cohort Study. Can Respir J (2016) 0.75

Invasive aspergillosis in a patient with idiopathic thrombocytopenic purpura without underlying lung disease. Thorax (1992) 0.75

Resolution of aspergillosis in neuroimaging of an immunocompromised patient with pulmonary and cerebral lesions. Asian J Neurosurg (2016) 0.75

Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary Aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/ MSG and ICU criteria. BMC Infect Dis (2017) 0.75

Aspergilloma in a patient with a history of TB. BMJ Case Rep (2014) 0.75

Articles cited by this

Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) (1970) 5.98

Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med (1976) 5.16

Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest (1982) 4.71

Clinical and immunologic significance of Aspergillus fumigatus in the sputum. Am Rev Respir Dis (1959) 4.03

Aspergillosis complicating neoplastic disease. Am J Med (1973) 3.80

Fungal infections in liver transplant recipients. Transplantation (1985) 3.07

Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann Intern Med (1984) 2.80

In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis (1984) 2.69

Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine (Baltimore) (1982) 2.62

Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J Clin Invest (1985) 2.22

Effects of corticosteroid therapy on human monocyte function. N Engl J Med (1975) 1.96

Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med (1986) 1.81

Effects of corticosteroids on human monocyte function. J Clin Invest (1974) 1.81

Pulmonary aspergillosis: an analysis of 41 patients. Ann Thorac Surg (1976) 1.62

Fatal acute pulmonary aspergillosis in two children of one family. Arch Dis Child (1966) 1.56

Invasive pulmonary aspergillosis associated with influenza. JAMA (1979) 1.43

Disseminated Aspergillus ustus infection following cardiac surgery. Am J Clin Pathol (1983) 1.19

Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts. Rev Infect Dis (1986) 1.16

Serious infectious complications of corticosteroid therapy for COPD. Chest (1989) 0.98

Multiple pulmonary aspergillomas in acute leukemia. Cancer (1971) 0.98

Fatal disseminated aspergillosis in an asthmatic patient treated with corticosteroids. Chest (1983) 0.95

Fungi in the sputum of normal men. Mycopathol Mycol Appl (1974) 0.93

Invasive pulmonary aspergillosis in a non-immunosuppressed patient: successful management with systemic amphotericin and flucytosine and inhaled amphotericin. Thorax (1984) 0.93

Invasive pulmonary aspergillosis associated with aspergilloma in sarcoidosis. South Med J (1983) 0.93

Invasive aspergillosis of the lung and pericardium in a nonimmunocompromised 33 year old man. Am J Med (1981) 0.93

Aspergillus pneumonia--a cluster of four cases in an intensive care unit. S Afr Med J (1977) 0.89

Invasive pulmonary aspergillosis in an apparently nonimmunocompromised host. Am J Med (1980) 0.89

Pulmonary berylliosis on corticosteroid therapy, with cavitating lung lesions and aspergillomata--report on a fatal case. Postgrad Med J (1987) 0.89

Miliary aspergillosis associated with alcoholism. AJR Am J Roentgenol (1978) 0.86

Case report: invasive pulmonary aspergillosis in a nonimmunosuppressed patient. Am J Med Sci (1979) 0.86

Fungal pneumonia (Part 4): invasive pulmonary aspergillosis. Chest (1981) 0.84

Aspergillosis. An unusual presentation. Am Rev Respir Dis (1969) 0.81

Primary pulmonary aspergillosis. A case report. N C Med J (1972) 0.81

Disseminated Strongyloides stercoralis and Aspergillus fumigatus presenting as diffuse interstitial pneumonitis in a steroid-dependent chronic obstructive pulmonary disease patient. Henry Ford Hosp Med J (1988) 0.80

Rapidly progressive pneumonia in a patient with chronic obstructive pulmonary disease. Chest (1989) 0.79

A non-immunosuppressed patient with presumably invasive pulmonary aspergillosis and a favourable outcome. Neth J Med (1983) 0.79

[Disseminated invasive aspergillosis associated with Mycoplasma pneumoniae infection]. Rev Mal Respir (1987) 0.78

Primary pulmonary aspergillosis with high fibrinolytic activity in the aortic intima. Chest (1972) 0.78

Articles by these authors

Chronic-intermittent hypoxia: a model of sympathetic activation in the rat. Respir Physiol (2000) 1.16

Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter. Chest (2000) 1.12

Assessment of oral midazolam limited sampling strategies to predict area under the concentration time curve (AUC) during cytochrome P450 (CYP) 3A baseline, inhibition and induction or activation. Int J Clin Pharmacol Ther (2010) 1.06

In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics. Pharmacogenetics (2001) 1.01

Effects of hemodialysis on sleep apnea syndrome in end-stage renal disease. Clin Nephrol (1990) 0.94

Immediate-early gene expression in cerebral cortex following exposure to chronic-intermittent hypoxia. Brain Res (2000) 0.90

Sleep related respiratory disorders in end-stage renal disease patients on peritoneal dialysis. Perit Dial Int (1992) 0.89

Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders. Am J Psychiatry (1995) 0.83

Beneficial effect of low-dose transdermal estrogen on bleeding time and clinical bleeding in uremia. Am J Kidney Dis (1995) 0.82

Chronic-intermittent hypoxia induces immediate early gene expression in the midline thalamus and epithalamus. Brain Res (2000) 0.82

Transgenic avian-derived recombinant human interferon-alpha2b (AVI-005) in healthy subjects: an open-label, single-dose, controlled study. Int J Clin Pharmacol Ther (2007) 0.81

Comparison of methods for identifying early methotrexate-induced hepatotoxicity in patients with rheumatoid arthritis. J Nucl Med (1993) 0.81

Comparison of methods for calculating glomerular filtration rate: technetium-99m-DTPA scintigraphic analysis, protein-free and whole-plasma clearance of technetium-99m-DTPA and iodine-125-iothalamate clearance. J Nucl Med (1990) 0.80

Pharmacokinetics and safety of single intravenous infusions of the adenosine agonist, AMP 579, in patients with end-stage renal insufficiency. J Clin Pharmacol (2000) 0.79

Rapidly progressive pneumonia in a patient with chronic obstructive pulmonary disease. Chest (1989) 0.79

Simvastatin does not affect CYP3A activity, quantified by the erythromycin breath test and oral midazolam pharmacokinetics, in healthy male subjects. J Clin Pharmacol (2000) 0.76

Noninvasive venous examinations as a screening test for pulmonary embolism. Arch Intern Med (1987) 0.75

Mineralocorticoid activity of 19-nor-corticosterone and 19-nor-progesterone in the toad bladder. Endocrinology (1984) 0.75

Success of prolonged hibernation of subcutaneously-placed peritoneal dialysis catheters. Perit Dial Int (2002) 0.75

Benign fibrous mesothelioma of the pleura: MR imaging findings. AJR Am J Roentgenol (1995) 0.75

The cost of lavage. Chest (1989) 0.75

Spurious hypochloremia and renal insufficiency. Ann Intern Med (1985) 0.75

Safety and efficacy of total dose iron dextran administration in patients on home renal replacement therapies. Perit Dial Int (1999) 0.75

Paradoxical hypotension and bradycardia after intravenous arginine vasopressin. J Clin Pharmacol (1998) 0.75

The cost of lavage sample interpretation. Chest (1988) 0.75

Differing effects of the anxiolytic agents buspirone and diazepam on control of breathing. Clin Pharmacol Ther (1991) 0.75

gamma-Aminobutyric acid contributes to modulation of cardiorespiratory control after chronic ventilatory loading. Respir Physiol (1997) 0.75